Registration Rights Agreement giving Arsenal demand and underwritten offering registration rights for resale of its securities.
| Officer | Age | In this role | Source |
|---|---|---|---|
|
Jon Resnick
Also a director
Chief Executive Officer
|
Not stated | Not stated | |
|
Faiz Mohammed
Interim CFO
Title from the Form 4 dated Sep 1, 2026
|
Not stated | Not stated | |
|
John Reynders
Also a director
Chief Financial Officer
Title from the Form 4 dated May 14, 2026
|
Not stated | Not stated | |
|
Daniel D. Corcoran
Senior Vice President, General Counsel and Secretary
|
59 |
Since 2024
2 years
|
|
|
Rona S. Anhalt
Chief Human Resources Officer
|
61 |
Since 2024
2 years
|
|
|
Robert A. Aspbury
PRESIDENT, PREDICTIVE TECH
Title from the Form 4 dated May 11, 2026
|
54 | Not stated | |
|
Adrian K. McKemey
President, Certara Drug Development Solutions
|
61 |
Since 2025
1 year
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Registration Rights Agreement giving Arsenal demand and underwritten offering registration rights for resale of its securities.
Letter Agreement under which Arsenal is prohibited from transferring shares acquired in the EQT/Arsenal transaction until December 8, 2024.
Amendment No. 1 to the Letter Agreement extending Arsenal's transfer restriction on acquired shares until April 14, 2026.
Stockholders Agreement giving Arsenal the right to nominate up to two directors to the Board, subject to ownership thresholds.
Loading...